Picture of Caplin Point Laboratories logo

CAPLIPOINT — Caplin Point Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Caplin Point Laboratories Says Unit Gets USFDA Approval For Procainamide Hydrochloride Injection

Feb 5 (Reuters) - Caplin Point Laboratories Ltd
 CAPL.NS :
    * UNIT GETS USFDA APPROVAL FOR PROCAINAMIDE HYDROCHLORIDE
INJECTION

Source text:  ID:nBSEbYGW4k 
Further company coverage:  CAPL.NS 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Caplin Point Laboratories

See all news